Targeting miR-335 to Treat Malignant Astrocytoma
Author Information
Author(s): Shu Minfeng, Zheng Xiaoke, Wu Sihan, Lu Huimin, Leng Tiandong, Zhu Wenbo, Zhou Yuehan, Ou Yanqiu, Lin Xi, Lin Yuan, Xu Dong, Zhou Yuxi, Yan Guangmei
Primary Institution: Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China
Hypothesis
The study investigates the role of miR-335 in promoting growth and invasion in malignant astrocytoma cells.
Conclusion
Inhibiting miR-335 suppresses tumor growth and induces apoptosis in malignant astrocytoma cells.
Supporting Evidence
- MiR-335 levels are elevated in malignant astrocytoma cells.
- Inhibition of miR-335 leads to growth arrest and apoptosis in astrocytoma cells.
- Daam1 is identified as a direct target of miR-335.
Takeaway
This study shows that a tiny molecule called miR-335 helps brain tumors grow, and blocking it can make the tumors shrink.
Methodology
The study used cell culture experiments, including viability assays, colony formation assays, and in vivo xenograft models to assess the effects of miR-335 inhibition.
Limitations
The study primarily focuses on in vitro and in vivo models, which may not fully replicate human tumor behavior.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website